Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
DSCI [NASD]
Derma Sciences Inc.
Index- P/E- EPS (ttm)-1.52 Insider Own1.00% Shs Outstand25.25M Perf Week1.81%
Market Cap213.11M Forward P/E- EPS next Y-1.64 Insider Trans2.43% Shs Float23.82M Perf Month-8.16%
Income-35.60M PEG- EPS next Q-0.43 Inst Own87.60% Short Float6.04% Perf Quarter-0.12%
Sales81.60M P/S2.61 EPS this Y-44.30% Inst Trans-2.56% Short Ratio21.01 Perf Half Y-17.09%
Book/sh5.32 P/B1.59 EPS next Y-1.90% ROA-25.80% Target Price15.94 Perf Year-27.18%
Cash/sh3.35 P/C2.52 EPS next 5Y- ROE-28.10% 52W Range7.88 - 15.51 Perf YTD-22.00%
Dividend- P/FCF- EPS past 5Y-11.30% ROI-31.40% 52W High-45.58% Beta0.91
Dividend %- Quick Ratio8.30 Sales past 5Y9.70% Gross Margin35.70% 52W Low7.11% ATR0.27
Employees258 Current Ratio9.70 Sales Q/Q-8.60% Oper. Margin-43.60% RSI (14)46.69 Volatility2.64% 3.19%
OptionableYes Debt/Eq0.00 EPS Q/Q-55.20% Profit Margin-43.60% Rel Volume0.58 Prev Close8.30
ShortableYes LT Debt/Eq0.00 EarningsAug 07 BMO Payout- Avg Volume68.53K Price8.44
Recom1.50 SMA20-2.55% SMA50-2.21% SMA200-17.18% Volume39,584 Change1.69%
Aug-14-14Reiterated Oppenheimer Outperform $19 → $18
Mar-17-14Reiterated Oppenheimer Outperform $19 → $21
Jul-06-11Initiated Oppenheimer Outperform $21
Feb-09-11Reiterated Rodman & Renshaw Mkt Outperform $13 → $25
May-14-10Initiated Rodman & Renshaw Mkt Outperform $13
Nov-25-14 02:05PM  Derma Sciences To Participate in Two Upcoming Investor Conferences in December Business Wire
Nov-15-14 01:04PM  DERMA SCIENCES, INC. Financials EDGAR Online Financials
Nov-14-14 09:21AM  Derma Sciences to Participate in Canaccord Genuity Medical Technologies and Diagnostics Forum Business Wire
Nov-10-14 07:39AM  Derma Sciences posts 3Q loss AP -6.18%
07:30AM  Derma Sciences Reports Third Quarter Financial Results Business Wire
Nov-07-14 05:27PM  DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
06:19AM  Is a Surprise Coming for Derma Sciences (DSCI) This Earnings Season? Zacks
Nov-06-14 07:30AM  Newly Published Final CMS Payments for 2015 Favorably Impact Derma Sciences TCC-EZ® and AMNIOEXCEL® Business Wire
Nov-04-14 08:30AM  Derma Sciences to Hold Third Quarter Financial Results Conference Call on November 10th Business Wire
Oct-23-14 11:58AM  Derma Sciences Presented Clinical Evidence And Data On Its Tissue Regeneration Products for Diabetic Foot Ulcers At Fall 2014 Symposium On Advanced Wound Care PR Newswire
Oct-17-14 02:37PM  Derma Sciences Showcases "Off-Loading Your Diabetic Foot Ulcer, An Actor's Story," a Patient Video Featuring Actor and Director Stephen Furst and his Experience with TCC-EZ® PR Newswire
Aug-12-14 09:16AM  Derma Sciences to Present at Canaccord Genuity 34th Annual Growth Conference on August 14 Business Wire
Aug-07-14 11:00AM  Derma Sciences Inc Earnings Call scheduled for 11:00 am ET today CCBN -7.20%
07:30AM  Derma Sciences Reports Second Quarter Financial Results Business Wire
07:07AM  Q2 2014 Derma Sciences, Inc. Earnings Release - Before Market Open CCBN
Aug-06-14 05:09PM  DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Aug-01-14 07:30AM  Derma Sciences to Hold Second Quarter Financial Results Conference Call on August 7th Business Wire
Jul-25-14 07:30AM  Derma Sciences CEO Discusses Continued Growth of MEDIHONEY® at Comvita Annual Meeting of Shareholders Business Wire
Jul-22-14 09:02AM  Derma Sciences announces Veterans Administration adds AMNIOEXCEL® to its Federal Supply Schedule Business Wire
Jun-19-14 07:47AM  Derma (DSCI) is in Overbought Territory: What's Next? Zacks
Jun-13-14 03:59PM  Derma Sciences, Inc. to Webcast June 17th Analyst Day Business Wire
May-29-14 09:00PM  [video] Derma Sciences CEO: Medihoney Sales Sweet and Getting Sweeter at TheStreet
May-23-14 04:50PM  DERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote o EDGAR Online
May-22-14 11:10AM  Derma Sciences management to meet with Oppenheimer at theflyonthewall.com
May-09-14 07:39PM  Derma Sciences' (DSCI) CEO Ed Quilty on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
May-08-14 11:00AM  Derma Sciences, Inc. Earnings Call scheduled for 11:00 am ET today CCBN -8.31%
07:36AM  Derma Sciences affirms FY14 net sales view $92M, consensus $91.78M at theflyonthewall.com
07:35AM  Derma Sciences reports Q1 EPS (46c), consensus (32c) at theflyonthewall.com
07:30AM  Derma Sciences Reports First Quarter Financial Results Business Wire
07:07AM  Q1 2014 Derma Sciences, Inc. Earnings Release - Before Market Open CCBN
May-07-14 05:18PM  DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
May-06-14 11:32AM  Derma Sciences to Present at Sidoti Semiannual Micro-Cap Conference on May 9 Business Wire
May-02-14 05:02PM  Ed Quilty, CEO Of Derma Sciences, Outlines His Strategy To Build A Premier Wound Healing Company at Seeking Alpha
Apr-30-14 10:12AM  Derma Sciences to Hold First Quarter Financial Results Conference Call on May 8th Business Wire
07:00AM  3 Stocks Under $10 Making Big Moves at TheStreet
Apr-23-14 07:30AM  Derma Sciences Products to Be Featured in 10 Posters and Two Educational Programs at the SAWC Conference; Company Launches New Corporate Branding Campaign Business Wire
Mar-27-14 04:36PM  DERMA SCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Mar-14-14 04:34PM  Derma Sciences' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
11:00AM  Derma Sciences, Inc. Earnings Call scheduled for 11:00 am ET today CCBN
07:30AM  Derma Sciences Reports Fourth Quarter Financial Results, Provides Commercial Update Including Sales Force Expansion and Progress in Launching New Placental-Derived Tissue Products Business Wire
07:07AM  Q4 2013 Derma Sciences, Inc. Earnings Release - Before Market Open CCBN
Mar-13-14 05:30PM  DERMA SCIENCES, INC. Files SEC form 10-K, Annual Report EDGAR Online
Mar-10-14 07:30AM  Derma Sciences to Hold Fourth Quarter Financial Results Conference Call on March 14th Business Wire
Mar-04-14 07:30AM  Derma Sciences to Present at the 26th Annual ROTH Conference Business Wire
Feb-28-14 10:05AM  Evaluate Biotech Stocks With Cynicism: Debjit Chattopadhyay at Seeking Alpha
Feb-19-14 01:17PM  Derma Sciences: A Not Well Followed Growth Company With Solutions For Diabetic Foot Ulcers at Seeking Alpha
Feb-05-14 03:30PM  3 Micro-Cap Stocks With Triple-Digit Upside StreetAuthority Network
Jan-31-14 06:34AM  Can Derma Sciences (DSCI) Continue to Rise? Zacks
Jan-30-14 05:43AM  Derma Sciences (DSCI) Jumps: Stock Rises 6.2% Zacks
Jan-29-14 10:17AM  Derma Sciences Closes $86 Million Underwritten Public Offering of Common Stock, Including Full Over-Allotment Business Wire +6.15%
Jan-27-14 05:30PM  DERMA SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibit EDGAR Online
Jan-24-14 09:00AM  Derma Sciences Announces Pricing of Underwritten Public Offering of Common Stock Business Wire
Jan-23-14 04:01PM  Derma Sciences Announces Commencement of Public Offering of Common Stock Business Wire
Jan-21-14 04:27PM  DERMA SCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
Jan-17-14 05:13PM  DERMA SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financ EDGAR Online
Jan-16-14 07:00AM  Derma Sciences Announces Record Revenues for the 2013 Fourth Quarter and Full Year, Introduces 2014 Revenue Guidance, Provides Update on DSC127 Phase 3 Clinical Trials Business Wire
Jan-14-14 10:47AM  Stocks: Insiders Buy at Opko Health and DDR; Ironwood Pharmaceuticals Sees a Sale at Minyanville
09:18AM  Derma Sciences Enters the Skin Substitute Market with Licensing Agreement for Innovative Amniotic Membrane Wound Care Products Business Wire
Dec-20-13 06:03PM  Nasdaq stocks posting largest volume increases AP
Dec-04-13 09:00AM  Derma Sciences to Present at the Oppenheimer & Co. Inc. 24th Annual Healthcare Conference Business Wire
Nov-25-13 10:45AM  INSERTING and REPLACING Derma Sciences to Participate in the 25th Annual Piper Jaffray Healthcare Conference Business Wire
Nov-14-13 05:55AM  Derma Sciences assumed with an Outperform at Oppenheimer at theflyonthewall.com
Nov-13-13 03:09PM  Derma Sciences' CEO Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha
11:00AM  Derma Sciences, Inc. Earnings Call scheduled for 11:00 am ET today CCBN
07:30AM  Derma Sciences Reports Third Quarter Financial Results Business Wire
07:07AM  Q3 2013 Derma Sciences, Inc. Earnings Release - Before Market Open CCBN
Nov-12-13 04:29PM  DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Derma Sciences, Inc. operates as a tissue regeneration company in the wound care market. It operates in three segments: Advanced Wound Care, Traditional Wound Care, and Pharmaceutical Wound Care. The company offers Medihoney dressings for managing non-chronic and hard-to-heal wounds, such as chronic ulcers, burns, and post-operative wounds; TCC-EZ total contact cast system for patients with diabetic foot ulcers; AMNIOEXCEL for tissue repair and regeneration; and AMNIOMATRIX, which is used as a wound covering in the treatment of localized tissue defects. It also provides Xtrasorb dressings that convert fluid within the dressings to a gel and lock the exudates into the dressings; Bioguard dressings for prophylactic use in the prevention of hospital or community acquired infections through wound sites; ALGICELL AG antimicrobial dressings; and occlusive dressings, such as hydrocolloids, foams, hydrogels, alginates, additional silver antimicrobial dressings, cleansers, and DERMAGRAN products. In addition, the company offers gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages, and other compression devices; adhesive bandages and related first aid products; wound closure strips, nasal tube fasteners, and catheter fasteners; and general purpose and specialized skin care products. Further, it develops DSC127, an angiotensin analog that is in Phase III clinical trials for the treatment of diabetic foot ulcers and preclinical testing for scar reduction. The company sells its products to various health care providers, such as wound care centers, extended care facilities, acute care facilities, home health care agencies, physicians' offices, nursing homes, hospitals, and clinics through direct sales and manufacturers' representatives, independent distributors, and retail channels primarily in the United States, Canada, and the United Kingdom. Derma Sciences, Inc. was founded in 1984 and is headquartered in Princeton, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STAFFORD C RICHARDDirectorNov 25Sale8.261,77514,66236,325Nov 26 04:37 PM
STAFFORD C RICHARDDirectorNov 18Sale8.593,25027,91838,100Nov 19 07:49 PM
STAFFORD C RICHARDDirectorNov 17Sale8.501,80015,30041,350Nov 19 07:49 PM
STAFFORD C RICHARDDirectorNov 14Sale8.455734,84243,150Nov 14 05:09 PM
STAFFORD C RICHARDDirectorNov 13Sale8.512,00017,02043,723Nov 14 05:09 PM
STAFFORD C RICHARDDirectorNov 12Sale8.472,50021,17545,723Nov 14 05:09 PM
WILLS STEPHEN TDirectorMay 23Option Exercise0.008,750094,821May 28 04:02 PM
STAFFORD C RICHARDDirectorMay 23Option Exercise5.608,75049,00048,223May 28 04:00 PM
Wolfenson BarrySee RemarksMay 19Buy8.795,75050,54375,085May 19 05:19 PM
Wolfenson BarrySee RemarksMay 16Buy8.795,50048,34569,335May 19 05:19 PM
QUILTY EDWARD JPresident & CEOMay 16Buy8.7010,00087,000170,172May 19 05:13 PM
CONJEEVARAM SRINIDirectorApr 21Option Exercise5.608,75049,00053,000Apr 23 04:58 PM
COLE ROBERT CSee RemarksFeb 14Option Exercise12.403,12538,75062,938Feb 19 05:40 PM
Eigner FredericExecutive VP - OperationsFeb 14Option Exercise12.403,75046,50050,300Feb 19 05:37 PM
YETTER JOHN EEVP, Finance & CFOFeb 14Option Exercise12.403,12538,75053,709Feb 19 05:35 PM
QUILTY EDWARD JPresident & CEOFeb 14Option Exercise12.406,25077,500166,043Feb 19 05:33 PM